Mankind Pharma (MANKIND) Share Price Rises 2.12% to Rs 2,323.30
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Mankind Pharma Share Price is higher today at Rs 2,323.30, up 2.12% from the previous close of Rs 2,275, while market capitalisation stands at Rs 93,967.76 Cr. The move places Mankind Pharma Share Price in focus in the healthcare space as investors track the stock’s price rise, valuation and sector comparison. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. The latest Univest figures show a clear intraday share price gain without a stated trigger, so the key point for readers is the verified move itself and the financial context around it. In today’s Mankind Pharma Stock News flow, the useful question is not only why Mankind Pharma Share Price is rising today, but also how the stock fits against its industry benchmark and peer set.
Mankind Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,323.3 |
| Previous Close | Rs 2,275 |
| Today's Move | Rs 48.3 (+2.12%) |
| Open | Rs 2,275 |
| High | Rs 2,348 |
| Low | Rs 2,270 |
| Market Capitalisation | Rs 93,967.76 crore |
| Market Cap Category | Large Cap |
Mankind Pharma Ltd. (MANKIND) rose to Rs 2,323.3 from the previous close of Rs 2,275, a move of Rs 48.3 or 2.12%. The stock opened at Rs 2,275, reached a high of Rs 2,348, recorded a low of Rs 2,270.
Mankind Pharma Share Price is trading at Rs 2,323.30, higher by Rs 48.30 or 2.12% from the previous close. The stock opened at Rs 2,275, touched a high of Rs 2,348 and a low of Rs 2,270 during the day. This is a clean intraday share price rise in Mankind Pharma Share Price, with the stock holding above its opening level and moving within a relatively tight range around the open. For readers following Mankind Pharma Share Price Today, the important facts are the exact move, the opening level and the day’s band rather than any unsupported story around the move. Mankind Pharma Share Price Live action also keeps the stock among the names showing a notable share price update in healthcare. The next layer of analysis is the fundamental base behind Mankind Pharma Share Price.
Mankind Pharma Ltd. (MANKIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 93,967.76 crore |
| P/E Ratio | 46x |
| P/B Ratio | 5.58x |
| ROE | 12.69% |
| ROCE | 13.24% |
| EPS | Rs 49.45 |
| Book Value Per Share | Rs 407.39 |
| Dividend Yield | 0.04% |
Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 46x, P/B 5.58x, ROE 12.69%, ROCE 13.24%. Read together, these ratios describe the company’s position rather than a recommendation.
Mankind Pharma Ltd. has a market capitalisation of Rs 93,967.76 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 46x, P/B at 5.58x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 46x |
| Benchmark Median P/E | 30.95x |
| Benchmark Average P/E | 46.82x |
| Benchmark P/E Range | 3.1x to 629.67x |
| Company P/B Ratio | 5.58x |
| Benchmark Median P/B | 2.82x |
| Company ROE | 12.69% |
| Benchmark Median ROE | 10.96% |
| Company ROCE | 13.24% |
| Benchmark Median ROCE | 13.01% |
| Company Market Capitalisation | Rs 93,967.76 crore |
| Benchmark Median Market Cap | Rs 720.23 crore |
Mankind Pharma Ltd. (MANKIND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 46x, which is above the benchmark median of 30.95x, a difference of +48.63%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 10.96%, a difference of +15.78%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is above the benchmark median of 13.01%, a difference of +1.77%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,22,282.95 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,762.03 | 83.68 | 13.86 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,447.74 | 79.53 | 19.32 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,12,149.36 | 24.85 | 4.16 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,250.29 | 101.75 | 19.73 | 18.31 | 18.2 |
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 46x compared with the displayed peer median of 79.53x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 12.69% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 93,967.76 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Mankind Pharma
- Mankind Pharma Share Price is up 2.12% today, with Rs 48.30 added over the previous close.
- The stock is trading at Rs 2,323.30, with the day’s range stretching from Rs 2,270 to Rs 2,348.
- Mankind Pharma Fundamental Analysis shows a P/E of 46, a P/B of 5.58, ROE of 12.69% and ROCE of 13.24%.
- The company’s market cap of Rs 93,967.76 Cr keeps Mankind Pharma Share Price in a sizeable healthcare position.
- The industry benchmark shows Mankind Pharma Share Price at a premium to the same industry median P/E and P/B.
About Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is known for medicines and healthcare products across its business lines, and its market position is reflected in a market capitalisation of Rs 93,967.76 Cr. Mankind Pharma Share Price today reflects investor interest in a large listed pharmaceutical company with a reported P/E of 46, P/B of 5.58, EPS of 49.45 and book value of Rs 407.39. Dividend yield stands at 0.04%, which is a small cash-yield profile relative to the current Mankind Pharma Share Price. In simple terms, the business sits in a sector where valuation, returns and earnings quality are closely watched. That makes Mankind Pharma Share Price relevant not only as a live quote, but also as a stock whose financial metrics shape how investors read the company’s standing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Mankind Pharma Share Price rising today?
Ans. Mankind Pharma Share Price is up 2.12% to Rs 2,323.30 in today’s trade. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Mankind Pharma Share Price today?
Ans. Mankind Pharma Share Price today is Rs 2,323.30, compared with the previous close of Rs 2,275. The stock is trading higher by Rs 48.30, which marks a 2.12% rise.
What is the market capitalisation of Mankind Pharma?
Ans. Mankind Pharma market capitalisation stands at Rs 93,967.76 Cr. That places Mankind Pharma Share Price within a large listed healthcare business context in the Pharmaceuticals & Drugs industry.
How does Mankind Pharma Share Price compare with its industry benchmark?
Ans. Mankind Pharma Share Price trades at a P/E of 46 versus the industry median of 30.95 and the average of 46.82. Its P/B of 5.58 is also above the benchmark median and average.
What do ROE and ROCE show for Mankind Pharma?
Ans. Mankind Pharma reports ROE of 12.69% and ROCE of 13.24%. These figures show how Mankind Pharma Share Price is backed by mid-range return ratios relative to the same industry benchmark.
What are the key valuation metrics for Mankind Pharma Share Price?
Ans. Key valuation metrics include a P/E of 46 and a P/B of 5.58. EPS is 49.45 and book value is Rs 407.39, which adds context to Mankind Pharma Share Price.
How does Mankind Pharma compare with peers?
Ans. Against peers such as Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd. and Lupin Ltd., Mankind Pharma Share Price carries a higher P/E than several names, while ROE and ROCE sit in a moderate range.
What is Mankind Pharma Share Price update during the day?
Ans. Mankind Pharma Share Price opened at Rs 2,275, touched Rs 2,348 and moved to Rs 2,323.30. The stock stayed within a narrow intraday band and remained above the previous close.
Track Mankind Pharma Share Price on Univest
Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Mankind Pharma Share Price on Univest for live updates, valuation ratios, 52-week levels and company insights in one place. Univest also helps compare Mankind Pharma Share Price with healthcare peers, sector benchmarks and fundamental ratios without losing the market context. If you are following Mankind Pharma Share Price Today or Mankind Pharma Stock News, the platform keeps the latest price, market cap and analysis together for quick review.
